Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy

Abstract

The levels of fecal SCFAs in the IgAN patients were reduced, and correlated with clinical parameters and gut microbiota, which may be involved in the pathogenesis of IgAN, and this finding may provide a new therapeutic approach.